Ethyl bromoacetate → HCID 22393105, compound
Reaction equation
Br[CH2:2][C:3]([O:5][CH2:6][CH3:7])=[O:4].C([O-])([O-])=O.[Na+].[Na+].[O:14]=[S:15]1(=[O:43])[C:21]2[CH:22]=[C:23]([OH:28])[C:24]([O:26][CH3:27])=[CH:25][C:20]=2[N:19]([C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)[CH2:18][C:17]([CH2:39][CH2:40][CH2:41][CH3:42])([CH2:35][CH2:36][CH2:37][CH3:38])[CH2:16]1>[Br-].C([N+](CCCC)(CCCC)CCCC)CCC.CC#N>[O:43]=[S:15]1(=[O:14])[C:21]2[CH:22]=[C:23]([O:28][CH2:2][C:3]([O:5][CH2:6][CH3:7])=[O:4])[C:24]([O:26][CH3:27])=[CH:25][C:20]=2[N:19]([C:29]2[CH:30]=[CH:31][CH:32]=[CH:33][CH:34]=2)[CH2:18][C:17]([CH2:39][CH2:40][CH2:41][CH3:42])([CH2:35][CH2:36][CH2:37][CH3:38])[CH2:16]1Participants
Procedure
Ethyl bromoacetate (0.13 ml), Na2CO3 (0.40 g) and tetrabutylammonium bromide (0.030 g) were added to a solution of 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methoxy-8-hydroxy-2,3,4,5-tetrahydro-1,5-benzothiazepine (synthesised by the of WO9616051 for the corresponding 3-butyl-3-ethyl analogue; 0.400 g, 0.927 mmol) in MeCN (10 ml). The suspension was heated under reflux overnight before most of the solvent was removed under reduced pressure. The crude product was extracted (DCM/H2O) and filtered through a short silica-column (DCM:EtOAc-1:4) to give the title compound 0.476 g (99%). NMR (400 MHz 0.65-0.85 (m, 6H), 0.95-1.65 (m, 8H), 3.00-3.15 (m, 2H), 3.50-3.80 (m, 2H), 3.70-3.80 (s, 3H), 5.60 (s, 1H), 5.65 (d, 1H), 7.00-7.60 (m, 17H), 8.05-8.20 (d, 1H).
Workup
- temperatureThe suspension was heated
- temperatureunder reflux overnight before most of the solvent
- customwas removed under reduced pressure
- extractionThe crude product was extracted (DCM/H2O)
- filtrationfiltered through a short silica-column (DCM:EtOAc-1:4)
Sources & evidence
- ORD record
- ord-a722e3e2ea544c948fedd51c81e6b591
- Source dataset
- uspto-grants-2005_06
- Patent number
- US06906058B2
Reaction notes
Loading…